“Novel Oral Anti Coagulants (NOACs) as Anti Thrombotic on Atrial Fibrillation Patients”, SCRIPTA SCORE Sci Med J., vol. 1, no. 2, p. 6, Feb. 2020, doi: 10.32734/scripta.v1i2.1232.